Implementation of Physiotherapy on COVID-19 Patients in ICU (PHYSIO-COVID)
Status
Conditions
Treatments
Details and patient eligibility
About
Despite new charachersitics of COVID-19 patients, critical care implementation seems to be similar to those with Acute Respiratory Distress Syndrome (ARDS) in intensive care units (ICU).
Regarding the initial gravity of these patients, sedation and neuromuscular blockers are usually administrated, increasing the risk to develope an ICU-acquired weakness which is directly correlated to morbi-mortality and a burden during recovery.
Respiratory symptoms are mostly related to dyspnoea and non-productive cough, with only 33% of COVID-19 patient having a bronchial hypersecretion ; consequently, chest physiotherapy is only implemented in after case-by-case evaluation.
This unprecedented situation requires to identify how physiotherapy is being implemented in COVID-19 patients in ICU.
This retrospective, multicentric study aims to identify the charactheristics of physiotherapy (type and time spent) implemented in Argentina, Belgium, Chili, France, Italy and Spain
Full description
- Demographics data : hospitalisation date, ICU date, COVID+ date, extubation date, discharge date, mortality
- ICU data : ventilatory mode, type of physiotherapy implemented (early rehabilitation, chest physiotherapy, time spent (minutes), number of interventions per day.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Age > 18 years
- Patient admitted in ICU
- Patient with COVID-19 diagnosis
Exclusion criteria
- Explicite denie to participate in the study
Trial design
150 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal